Web Analytics

3 Latest Announced Rounds

  • $38,000,000
    Series C

    1 Investors

    Financial Services
    Aug 5th, 2025
  • $8,000,000
    Unknown
    Pharmaceutical Manufacturing
    Aug 5th, 2025
  • $2,600,000
    Pre-Seed

    2 Investors

    Software Development
    Aug 5th, 2025
$1,267.05M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Matchpoint Therapeutics

start up
United States - Cambridge, Massachusetts
  • 17/10/2022
  • Series A
  • $100,000,000

Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines initially focused on immunology. For more information, please visit www.matchpointtx.com.


Related People

Andre TurenneFounder

Andre Turenne United States - Cambridge, Massachusetts

N/A